Advanced biotech equipment, driven by R&D investment and personalized medicine, is essential for scalable drug production and development into the next decade, according to a BCC Research report.

On October 18, 2025, the 67th (Autumn 2025) National Pharmaceutical Machinery Exposition & 2025 (Autumn) China International ...

Success with a smart VF is less about the screens and more about how people interact with the data and each other.

The partnership combines Körber's PAS-X MES platform with Pepperl+Fuchs' VisuNet interfaces for secure and regulatory ...

In this interview, Braj Panda shares how Industry 5.0 is ushering in a future where technology doesn’t just optimise—it ...

The joint approach facilitates a smooth transition between drug substance and product stages, optimising timelines.

President Trump’s second term has been marked by a flurry of company pledges to expand production in the United States. From ...

What is Real-Time Release Testing? Real-Time Release Testing (RTRT) is an advanced approach to biopharmaceutical manufacturing quality control that improves upon current systems. RTRT is defined as ...

Hovione, a global contract development and manufacturing organization, has completed the initial phase of a $100 million ...

In May 2025, the Trump administration issued an executive order titled “Regulatory Relief to Promote Domestic Production of Critical Medicines” directing the Food and Drug Administration (FDA) and the ...

After a pandemic-fueled lull the past few years, FDA inspections are back in full force. This week, a pair of Indian drugmakers have found themselves in the agency’s crosshairs. The FDA has handed ...